MORC4 and breast carcinoma: As for tumors, BA, a potent inhibitor of NF-κB, could inhibit migration and invasion in breast cancer by regulating miR-338-3p and MORC4 as well as reversing epithelial-to-mesenchymal transition by targeting β-catenin signaling (Zhou et al., 2017; Duan et al., 2019).